Usefulness of l-[3-18f]-α-methyl tyrosine (18F-FAMT) PET as therapeutic monitoring for patients with advanced lung cancer.
Kyoichi Kaira
No relevant relationships to disclose
Tetsuya Higuchi
No relevant relationships to disclose
Noboru Oriuchi
No relevant relationships to disclose
Noriaki Sunaga
No relevant relationships to disclose
Takeshi Hisada
No relevant relationships to disclose
Takayuki Asao
No relevant relationships to disclose
Yoshihito Tsushima
No relevant relationships to disclose
Masanobu Yamada
No relevant relationships to disclose